ACAD
36.55
+0.49
+1.36%
AEMD
6.26
+0.14
+2.2892%
APRI
0.334
-0.006
-1.7378%
ARNA
1.68
-0.1
-5.62%
ATEC
0.39
+0.03
+8.33%
CNAT
2.2
+0.01
+0.46%
CRXM
0.18
0.00
0.00%
CYTX
2.03
-0.02
-0.98%
DXCM
87.89
+3.26
+3.85%
GNMK
9.8
+0.25
+2.62%
HALO
9.24
-0.11
-1.18%
ILMN
150.76
-0.55
-0.36%
INNV
0.44
+0.04
+9.73%
INO
9.13
+0.08
+0.88%
ISCO
1.945
0.00
0.00%
ISIS
57.56
0.00
0.00%
LGND
132.55
+0.59
+0.45%
LPTN
2.1
+0.19
+9.95%
MBVX
0.675
+0.045
+7.143%
MEIP
1.37
-0.02
-1.44%
MNOV
6.48
-0.2
-2.99%
MRTX
5.08
-0.01
-0.20%
MSTX
0.439
+0.028
+6.709%
NBIX
49.51
+0.43
+0.88%
NUVA
61.54
-0.37
-0.60%
ONCS
1.74
+0.04
+2.35%
ONVO
4.06
+0.04
+1.00%
OREX
3.51
0.00
0.00%
OTIC
14.8
+0.13
+0.89%
QDEL
19.54
-0.09
-0.46%
RCPT
231.96
0.00
0.00%
RGLS
3.43
+0.01
+0.29%
RMD
65.93
+0.04
+0.06%
SCIE
0.004
0.00
-5.1282%
SPHS
4.38
+0.42
+10.61%
SRNE
6.3
0.00
0.00%
TROV
5.04
-0.04
-0.79%
VICL
4.03
-0.35
-7.99%
VOLC
18
0.00
0.00%
ZGNX
8.62
-0.04
-0.46%
ACAD
36.55
+0.49
+1.36%
AEMD
6.26
+0.14
+2.2892%
APRI
0.334
-0.006
-1.7378%
ARNA
1.68
-0.1
-5.62%
ATEC
0.39
+0.03
+8.33%
CNAT
2.2
+0.01
+0.46%
CRXM
0.18
0.00
0.00%
CYTX
2.03
-0.02
-0.98%
DXCM
87.89
+3.26
+3.85%
GNMK
9.8
+0.25
+2.62%
HALO
9.24
-0.11
-1.18%
ILMN
150.76
-0.55
-0.36%
INNV
0.44
+0.04
+9.73%
INO
9.13
+0.08
+0.88%
ISCO
1.945
0.00
0.00%
ISIS
57.56
0.00
0.00%
LGND
132.55
+0.59
+0.45%
LPTN
2.1
+0.19
+9.95%
MBVX
0.675
+0.045
+7.143%
MEIP
1.37
-0.02
-1.44%
MNOV
6.48
-0.2
-2.99%
MRTX
5.08
-0.01
-0.20%
MSTX
0.439
+0.028
+6.709%
NBIX
49.51
+0.43
+0.88%
NUVA
61.54
-0.37
-0.60%
ONCS
1.74
+0.04
+2.35%
ONVO
4.06
+0.04
+1.00%
OREX
3.51
0.00
0.00%
OTIC
14.8
+0.13
+0.89%
QDEL
19.54
-0.09
-0.46%
RCPT
231.96
0.00
0.00%
RGLS
3.43
+0.01
+0.29%
RMD
65.93
+0.04
+0.06%
SCIE
0.004
0.00
-5.1282%
SPHS
4.38
+0.42
+10.61%
SRNE
6.3
0.00
0.00%
TROV
5.04
-0.04
-0.79%
VICL
4.03
-0.35
-7.99%
VOLC
18
0.00
0.00%
ZGNX
8.62
-0.04
-0.46%
Home » Archive by Category

Xconomy

One Year After Gaffe, Acadia Gains FDA Nod For Parkinson’s Drug

April 29, 2016 – 5:58 pm

Last year’s shakeup and mea culpa at San Diego’s Acadia Pharmaceuticals (NASDAQ: ACAD) has paid off. The FDA said late today it has approved Acadia’s pimavanserin (Nuplazid), a…

[[Click headline to continue reading.]]

Join Maeda, Hillis, Jepsen, & More in Napa May 16-17—Get Your Invite

April 28, 2016 – 7:34 am

Carving out time to really ponder the future of our technology landscape can be touch, but it can also be incredibly valuable. And if that time is spent with some of the world’s great innovators,…

[[Click headline to continue reading.]]

Finistere, IFC Team Up on New Ag Fund Willow Hill Ventures

April 26, 2016 – 10:48 am

Agricultural technology startups face challenges finding the capital to scale their companies, but they also struggle to find the farmland to test their products. Two companies experienced in…

[[Click headline to continue reading.]]

West Coast Bio Roundup: Prince, Theranos, Second Genome, CytomX & More

April 22, 2016 – 3:30 am

The biggest biomedical news on this coast, that coast, or any coast this week is the death of Prince Rogers Nelson, 57, a man who did more to promote cardiovascular fitness than any drug maker could…

[[Click headline to continue reading.]]

Ready Or Not: Next Alzheimer’s Drugs Might Strain Health Systems

April 19, 2016 – 3:30 am

By 2029, more than 20 percent of people in the United States will be over the age of 65. That’s why the race to find effective treatments for Alzheimer’s disease feels urgent. A few…

[[Click headline to continue reading.]]

Agenda Posted For Napa Summit: Request Invite to Star-Studded Event

April 18, 2016 – 10:29 am

It’s four weeks until Napa Summit 2016: The Xconomy Retreat on the Economy, Jobs, and Growth. We have now posted the agenda, and we’d love to see you there. So request your invitation today to…

[[Click headline to continue reading.]]

West Coast Biotech Roundup: Theranos, Medivation, Juno, and More

April 15, 2016 – 6:36 am

Sean Parker, who made billions of dollars investing in Napster and Facebook, hosted a big party this week with Lady Gaga, John Legend, and a lot of movie stars. Oh, and Parker pledged $250 million to…

[[Click headline to continue reading.]]

Cydan, NEA’s Orphan Drug Accelerator, Targets Sickle Cell With Startup Imara

April 14, 2016 – 4:25 am

Cydan Development, New Enterprise Associates’s orphan drug startup accelerator, has taken a look at around 600 assets since it was formed some three years ago. Sifting through all these potential…

[[Click headline to continue reading.]]

EnsoData Raises $550K to Develop Software That Analyzes Sleep Data

April 13, 2016 – 3:45 pm

At an event last August featuring pitches from startups, EnsoData co-founder Chris Fernandez told audience members that his company was hoping to raise $300,000 in a seed funding round. EnsoData,…

[[Click headline to continue reading.]]

With Latest Startup, Harvard’s Verdine Again Aims at Elusive Targets

April 13, 2016 – 3:50 am

Harvard University chemical biologist and serial entrepreneur Greg Verdine has spent more than a decade trying to come up with different solutions for one critical problem in biotech: The majority of…

[[Click headline to continue reading.]]